- Previous Close
2.2900 - Open
2.2600 - Bid --
- Ask --
- Day's Range
2.2500 - 2.2980 - 52 Week Range
1.7100 - 3.1400 - Volume
194,056 - Avg. Volume
894,634 - Market Cap (intraday)
873.2M - Beta (5Y Monthly) 1.02
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1500 - Earnings Date Nov 6, 2024 - Nov 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.86
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
www.thecronosgroup.com356
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: CRON
View More
Performance Overview: CRON
Trailing total returns as of 10/23/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CRON
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CRON
View MoreValuation Measures
Market Cap
822.68M
Enterprise Value
-23.52M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.98
Price/Book (mrq)
0.77
Enterprise Value/Revenue
0.02
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-56.43%
Return on Assets (ttm)
-3.73%
Return on Equity (ttm)
-5.29%
Revenue (ttm)
101.78M
Net Income Avi to Common (ttm)
-57.37M
Diluted EPS (ttm)
-0.1500
Balance Sheet and Cash Flow
Total Cash (mrq)
848.19M
Total Debt/Equity (mrq)
0.19%
Levered Free Cash Flow (ttm)
-30.52M
Research Analysis: CRON
View MoreCompany Insights: CRON
CRON does not have Company Insights
Research Reports: CRON
View MoreCronos Remains Far From Critical Mass to Achieve Profitability; Cash Hoard Is Most of Its Value
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
RatingPrice TargetCronos Earnings: Shares Look Fairly Valued as Company’s Small Size Remains a Challenge
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
RatingPrice TargetCronos Is Unlikely to Generate Positive Adjusted EBITDA for the Foreseeable Future
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
RatingPrice TargetCronos Earnings: Surprising Progress on Narrowing Losses, but Small Size Still a Challenge
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.
RatingPrice Target